Agency of the United States Department of Health and Human Services
POPULARITY
Categories
357 episodes with fda
281 episodes with fda
183 episodes with fda
247 episodes with fda
229 episodes with fda
126 episodes with fda
183 episodes with fda
112 episodes with fda
147 episodes with fda
150 episodes with fda
273 episodes with fda
183 episodes with fda
178 episodes with fda
185 episodes with fda
53 episodes with fda
82 episodes with fda
75 episodes with fda
90 episodes with fda
65 episodes with fda
62 episodes with fda
135 episodes with fda
55 episodes with fda
70 episodes with fda
107 episodes with fda
107 episodes with fda
61 episodes with fda
68 episodes with fda
36 episodes with fda
96 episodes with fda
44 episodes with fda
50 episodes with fda
65 episodes with fda
44 episodes with fda
42 episodes with fda
105 episodes with fda
43 episodes with fda
64 episodes with fda
50 episodes with fda
47 episodes with fda
51 episodes with fda
61 episodes with fda
97 episodes with fda
78 episodes with fda
41 episodes with fda
38 episodes with fda
59 episodes with fda
64 episodes with fda
56 episodes with fda
55 episodes with fda
97 episodes with fda
73 episodes with fda
59 episodes with fda
49 episodes with fda
99 episodes with fda
After decades of stagnation and caution, the FDA is radically changing their advice on hormone replacement therapy for menopausal women. We speak to the FDA Commissioner about the new advice for women. Get the facts first with Morning Wire. Chevron: Build a brighter future right here at home. Visit https://Chevron.com/America to discover more. HelloFresh: Go to https://HelloFresh.com/MORNINGWIRE10FM now to Get 10 Free Meals + a Free Item for Life! - - - Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 - - -Privacy Policy: https://www.dailywire.com/privacy Learn more about your ad choices. Visit podcastchoices.com/adchoices
On this episode of Vitality Radio, Jared continues his deep dive into one of the most overlooked health threats of our time: endocrine-disrupting chemicals. If you haven't listened to Part 1 yet, hit pause and go back — the two episodes build on each other, and the full picture will make far more sense when heard in order.Here, we shift from identifying the problem to showing you how to clear it from your system naturally. This episode breaks down the detoxification phase of the long-awaited Endocrine Detox Protocol — built around four targeted formulas designed to support receptor clearance, liver pathways, gut integrity, and calcium balance to support healthy hormone signaling.If you've been struggling with stubborn symptoms, slow progress, or hormone fluctuations despite “doing everything right,” this episode will help you understand what's been missing — and how to finally address the upstream causes that matter.Products:LiverVitalityEndoCleanseBack On TractVital D3/K2 High PotencyVital D3/K2Magnesium BisglycinateAdditional Information:#588: The Hidden Epidemic Part 1: How Endocrine Disruptors Are Hijacking Your Health#507: Comprehensive Digestive Support to Get Your Gut ‘Back On Tract'!#565: D3, K2, Boron, and Silica: The Ultimate Synergy for Bones, Hormones, Arteries, and More!#258: Your Magnesium User's GuideVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
As the heroes pursue a lead on the missing merchant, they find themselves crossing paths with more denizens of the forest. Watch the video here: https://youtu.be/lUG0_zUoo3s Enter the Shadowdark at your gaming table by visiting https://www.thearcanelibrary.com/?utm_source=glasscannon This episode was sponsored by Foundry VTT and Norse Foundry. See why tabletop gamers everywhere have made the switch to Foundry Virtual Tabletop at https://foundryvtt.com/gcp For all your random number-generating needs, visit Norse Foundry at https://norsefoundry.com For simple, online access to personalized and affordable care for hair loss, visit https://hims.com/GCN (Individual results may vary. Based on studies of topical and oral minoxidil and finasteride. Featured products include compounded drug products, which the FDA does not approve or verify for safety, effectiveness, or quality. Prescription required. See website for full details, restrictions, and important safety information.) Go to www.HuckleberryRPG.com/preorder and use code: GCP5 for $5 off. CritHeads is available exclusively on Drive thru RPG, just search CritHeads Gaming at DriveThruRPG.com. Executive Producer and Gamemaster: Troy Lavallee Cast: Sydney Amanuel, Matthew Capodicasa, Skid Maher and Joe O'Brien Cinematographer: Matt Brodie Producer and Editor: Francis Mrema Audio Engineer and Graphics: CJ Paschall Production Coordinator: Michael Mooridian Art Direction: Josh Fisher Intro Song: "In the Shadowdark" by Jason Charles Miller Performed by: Jason Charles Miller with Sydney Amanuel Access exclusive podcasts, ad-free episodes, and so much more with a 30-day free trial using code "GCN30" at http://www.jointhenaish.com For more podcasts and livestreams or to catch the next stop on the tour, visit https://hubs.li/Q03cmWCk0 Watch new episodes when they premiere every Thursday at 8PM ET on youtube.com/theglasscannon. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this powerful and deeply personal episode, Ali sits down with Connie, a proud Single Mom by Choice whose path to motherhood was anything but traditional—and exactly right for her. Growing up with a Black military dad and a Taiwanese “Tiger Mom,” Connie always felt the weight of expectations about what family should look like. But as she approached her late 30s, knowing she always wanted to have kids, she decided to freeze her eggs. Later, her best friend gave her the clarity she needed: “Connie, if you want your baby, go get your baby. You don't need to do it the traditional way.” Connie opens up about what it was like navigating the SMBC journey as a woman of mixed race, including the emotional complexity of donor selection and the lack of Black sperm donors in U.S. banks. She shares how she found an amazing doctor and clinic, Dr. Joshua Klein of Extend Fertility -- aka Ali's doctor! Connie also talks about navigating IVF, getting pregnant (with twins!), giving birth during Covid and what life is like today, as a single mom of two five-year-olds.EPISODE SPONSORS: BEAUTIFUL BIRD AND WORK OF ARTAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “Beautiful Bird” tells the story of three parents, one incredible boy and a family built with love—and a little bit of science.Pre-orders are available now! The first 150 copies will be Personalized, Signed and Numbered! Don't miss out on this limited edition! Tap the link in bio and stories to order your copy today.When Helen decides to have a baby on her own, she welcomes Jack Bird into the world through IUI with the help of her friend, Aaron. But when Jack is born and needs extra care in the NICU, Aaron and his partner, Blake, fall in love with Jack, too. Together, the three join forces to raise Jack, proving that family isn't about how you start—it's about how you grow.Order yours now at https://www.infertileafgroup.com/booksFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipPHERDALIG: pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Affordable Care Act health insurance premiums expire on December 31st, but Congress has yet to come to a bipartisan agreement on policy ahead of that deadline. House Minority Leader Hakeem Jeffries (D-NY) explains his party's strategy and the affordability crisis for many Americans. Former CEO of the Cleveland Clinic Dr. Toby Cosgrove has hope for AI's impact on health care costs; he discusses the future of hospitals and medical innovation. Plus, leaders in the industry have penned a concerned letter to President Trump, the HHS, and the FDA about rare disease research and investment. Outside of health care, President Trump will lower tariffs on some Argentinian food products, and Ukrainian President Volodymyr Zelenskyy will work with the U.S. on a peace plan between Russia and Ukraine. Rep. Hakeem Jeffries - 13:48Dr. Toby Cosgrove - 26:16 In this episode:James Lankford, @SenatorLankfordHakeem Jeffries, @RepJeffriesBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinCameron Costa, @CameronCostaNY Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
You've heard us discuss neuromodulators on the podcast before, but they aren't one-size-fits-all. Vanessa Lee, RN (and founder of The Things We Do) is back to break down what sets Jeuveau® apart, who it suits, and how it stacks up in recent head-to-head data. (Plus, Sara shares her experience with it so far!) Then, we tackle your Slack Qs: subtle celeb-style tweaks on a budget, microneedling timelines for acne scarring, sun-spot solutions, rosacea care at home, and where high-frequency wands actually fit into your routine.Vanessa Lee was compensated by Evolus to appear in the first segment of this podcast.For full Product Information, including Boxed Warning and Medication Guide, visit evolusrx.com. To learn more, visit jeuveau.com. Jeuveau® (prabotulinumtoxinA-xvfs) is an FDA-approved prescription injectable treatment used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) inadults. There are risks with treatment ‒ effects of Jeuveau may spread hours to weeks after injection causing serious symptoms. Alert your doctor right away of difficulty swallowing, speaking, breathing, eye problems or muscle weakness, which can be signs of a life-threatening condition. Other serious risks include allergic reactions, heart or eye problems. The most common side effects are headache, eyelid drooping, upper respiratory infection, and increased white blood cell count. Ask your doctor about Jeuveau and whether it's right for you.*About 50% of patients begin showing improvement after two days. Most patients (~69%) achieve complete results by day 30. On average, Jeuveau patients receive three treatments per year.FTC disclosure: Thank you to Jeuveau for partnering with us on this episode. Intended for US audiences only.US-JUV-2500517Watch our episodes!CALL or TEXT US: 424-341-0426Instagram: @glossangelspod, @kirbiejohnson, @saratanTwitter: @glossangelespod, @kirbiejohnson, @saratanEmail: glossangelespodcast@gmail.com Hosted on Acast. See acast.com/privacy for more information.
What if your erection could tell you something deeper about your health—something even your doctor might miss?In this exclusive episode, Dr. Arthur Burnett, one of the leading experts in urology and a key figure in the science behind Viagra, joins the conversation. Together, we explore the real connection between erectile dysfunction, prostate cancer, and overall prostate health. We dive into what's fact, what's fiction, and why ED might be your body's first warning sign of something much bigger. Whether you're dealing with performance issues or concerned about your prostate, this episode is for you.Hit play now. Your health, and your future, may depend on it.--------------About Dr. Arthur BurnettDr. Arthur Burnett is a world-renowned urologist and professor at the Johns Hopkins School of Medicine, where he holds the prestigious Patrick C. Walsh Professorship in Urology. As Director of the Male Consultation Clinic and Vice Chair for faculty development at the James Buchanan Brady Urological Institute, he brings decades of groundbreaking expertise in erectile dysfunction, prostate cancer, and reconstructive urology.A pioneer in the discovery of nitric oxide's role in erections, Dr. Burnett's research was instrumental in the development of Viagra. He has performed over 3,000 nerve-sparing radical prostatectomies and authored more than 500 peer-reviewed publications. With honors from the NIH, FDA, and the American Urological Association, Dr. Burnett continues to lead the field in advancing male sexual and prostate health.Want to connect with Dr. Arthur Burnett? Visit the Johns Hopkins Urology website or find his books on Amazon to learn more about his work in men's health.--------------Resources mentioned:Modern Man CribMediterranean DietGood Morning Wood Smoothie--------------Curious about how you can boost your bedroom game and build lasting confidence? Check out the course at getwoodnow.com and start your journey to feeling like yourself again!--------------If you enjoyed this episode and want to learn more and get more tips, subscribe to The Modern Man newsletter for exclusive content delivered straight to your inbox! https://dranne.co/themodernman--------------Follow Me On:InstagramTwitterFacebookTikTokYouTube--------------For all links and resources mentioned on the show and where to subscribe to the podcast, please visit
Welcome to OncLive On Air®! OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. In today's episode, we had the pleasure of speaking with Harry P. Erba, MD, PhD, about the FDA approval of ziftomenib (Komzifti) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation who have no satisfactory alternative treatment options. Dr Erba is a professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine at the Duke University School of Medicine, as well as director of the Leukemia Program and director of Phase I Development in Hematologic Malignancies. He is also a member of the Duke Cancer Institute in Durham, North Carolina. In our exclusive interview, Dr Erba discussed the significance of this approval, key efficacy and safety findings from the pivotal phase 1/2 KOMET-001 trial (NCT04067336), and the role ziftomenib may play throughout the evolution of the AML treatment paradigm. _____ That's all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field. For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters. OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn. If you liked today's episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us! Thanks again for listening to OncLive On Air. *OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn. This content is a production of OncLive; this OncLive On Air podcast is supported by funding, however, content is produced and independently developed by OncLive.
In this episode of Walk, Don't Run to the Doctor, we take a deep dive into statins, their true benefits, their real risks, and the massive role lifestyle plays in shaping heart disease outcomes. Rather than accepting oversimplified medical advice, this episode empowers you to think critically, understand uncertainty in medicine, and make fully informed decisions about your own health. You'll learn how to interpret risk statistics (like relative vs absolute risk), why lifestyle may outperform medication for many people, and why statins are helpful for some—yet potentially unnecessary or harmful for others. If you've ever been told "your cholesterol is high, you need a statin," this episode will give you the tools to ask better questions and understand whether that advice truly applies to someone like you. Key Takeaways: -Medical uncertainty is real — many "facts" are actually opinions without solid or applicable evidence. -Statins help some people more than others: -Strong evidence for people who already had a heart attack. -Much smaller benefit (sometimes minimal) for healthy, active people without prior heart disease. -Absolute vs. relative risk matters: -A "25% reduction in risk" may really mean only 1 fewer event per 100 people. -Lifestyle changes can reduce risk by 50–80%, often outperforming statin benefits—especially for people who exercise, eat whole foods, avoid smoking, keep weight down, and drink moderately. -Statin risks are real: Muscle pain: up to 1 in 10 Diabetes risk increased: about 1 in 200 Possible cognitive impairment (enough for an FDA warning) Polypharmacy (multiple medications) increases uncertainty and side-effect risks. Get your copy of Good Food Great Medicine, 4th ed.: https://a.co/d/1D6hIYM More references can be found at www.GreatMed.org Would you like Dr. Hassell to answer your question on the air? Contact us! Phone/text: 503-773-0770 e-mail: info@GreatMed.org EIN: 88-326-7056 Write us a letter. We love to hear from you. This podcast is sponsored by our generous listeners. Send questions, comments, and support to: GreatMed.org 4804 NW Bethany Blvd., Suite I-2, #273 Portland OR 97229 Check out this video on Completely Rethinking the Link Between Statins, Cholesterol, & Heart Disease, w/ Dr. Aseem Malhotra: https://www.youtube.com/watch?v=-RU3Ouxt1vs&t=251s References from today's podcast: Ioannidis J. P. (2005). Why most published research findings are false. PLoS medicine, 2(8), e124. https://doi.org/10.1371/journal.pmed.0020124 Luo, Y., Liu, J., Zeng, J., & Pan, H. (2024). Global burden of cardiovascular diseases attributed to low physical activity. American journal of preventive cardiology, 17, 100633. https://doi.org/10.1016/j.ajpc.2024.100633 Ye, Z., Det al. (2025). Association of statins use and genetic susceptibility with incidence of Alzheimer's disease. The journal of prevention of Alzheimer's disease, 12(2), 100025. https://doi.org/10.1016/j.tjpad.2024.100025
AMT-130 was sold as the breakthrough Huntington's families have waited generations for — a one-shot gene therapy that “changes everything.” Researchers celebrated, headlines exploded, and desperate families finally believed they might be saved. But behind the hype, the FDA slammed the brakes, a leading scientist called out exaggerated claims, and truth collided with marketing. This episode exposes the divide: real science vs. false hope. We dig into the hype machine, the backlash, and why Huntington's families are being pushed into a letter-writing campaign to fix a mess they never deserved. If you're tired of miracles being promised and ripped away, this is the show you've been waiting for.
Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a landscape marked by significant scientific advancements, regulatory approvals, and strategic shifts that are reshaping the industry.Starting with Regeneron, the company's ophthalmic drug Eylea HD has recently secured two FDA approvals. These endorsements not only grant a new indication but also introduce a more flexible dosing regimen. This positions Eylea HD competitively against Roche's Vabysmo, highlighting the importance of regulatory navigation and strategic positioning in the pharmaceutical sector. These approvals come after extensive negotiations with both the FDA and third-party manufacturers, emphasizing the intricate processes involved in bringing a drug to market.In oncology, Bayer has achieved an accelerated FDA approval for Hyrnuo, a treatment targeting HER2-mutated non-small cell lung cancer. This move allows Bayer to challenge Boehringer Ingelheim's Hernexeos, underscoring the fiercely competitive nature of the oncology market. Such advancements are driven by innovative treatments that address specific genetic mutations in cancer patients, reflecting a broader trend towards precision medicine.Meanwhile, Moderna is investing heavily in mRNA production capabilities with a new $140 million facility in Norwood, Massachusetts. This development underscores Moderna's commitment to mRNA technology, which gained significant attention during the COVID-19 pandemic. The facility aims to establish robust domestic manufacturing infrastructures to mitigate supply chain vulnerabilities—a critical move considering recent global disruptions.Novartis is also making headlines with its plans for a flagship production hub in North Carolina. This expansion is expected to create 700 jobs and expand its manufacturing footprint by 700,000 square feet, highlighting Novartis's strategic emphasis on scaling up operations to meet growing demands and enhance production efficiency.In another strategic collaboration, Antheia has joined forces with Teva's TAPI division to enhance the commercialization prospects for its biosynthetic pipeline. This alliance marks a significant step toward advancing biologically derived pharmaceuticals, promising to revolutionize drug production through more sustainable and scalable alternatives to traditional chemical synthesis.On the regulatory front, Merck has received broad EU approval for a subcutaneous formulation of Keytruda. This development could significantly expand Keytruda's market reach across Europe, demonstrating how regulatory agility can extend drug lifecycles and maximize therapeutic impact across diverse patient populations.Compliance challenges remain prevalent, as illustrated by Pfizer and Tris Pharma's settlement of allegations related to ADHD medication Quillivant's quality control issues for $41.5 million. This case highlights ongoing efforts to ensure stringent quality standards within pharmaceutical manufacturing processes.Abbott is expanding its diagnostics portfolio through a $23 billion acquisition of Exact Sciences, known for its Cologuard colorectal cancer test. This acquisition indicates a strategic shift towards enhancing diagnostic capabilities alongside therapeutic offerings—a trend increasingly evident in holistic healthcare solutions.GSK is embarking on a $7 billion collaboration with biotechs Quotient and Profound through Flagship Pioneering. This partnership aims to leverage novel protein and genomic technologies to drive innovation in drug discovery and development, illustrating the industry's focus on integrating advanced biotechnological insights into traditional pharmaceutical frameworks.These developments collectively underscore crSupport the show
On week's episode, Eric Schmidt, Yaron Werber, Tess Cameron, and Sam Fazeli kick off with biotech M&A news, including Alkermes' $2.37 billion offer for Avadel, following Lundbeck's surprise bid. Next, the co-hosts discuss J&J's $3.05 billion cash acquisition of Halda - the highest-priced deal for a company at this stage. The group also covers Merck's acquisition of Cidara Therapeutics to strengthen its antiviral pipeline. They debate whether biotech M&A is becoming more competitive, what big pharma is prioritizing, and the role M&A is playing in the current biotech rally. The conversation then shifts to Washington policy news, including the CDC website updates suggesting vaccines haven't been proven not to cause autism, alleged tensions between RFK Jr. and Dr. Marty Makary over FDA leadership authority and management-style concerns Next, in regulatory news, the co-hosts overview the FDA's approval of Arrowhead's Redemplo for FCAS, priced at $60K, and its competition with Ionis' Tryngolza. Novo Nordisk's semaglutide price cut and conversations on drug pricing trends and the impact on competition are also mentioned. The episode concludes with an overview of Zymeworks positive data and shifting in business model, Nuvalent's positive data and $500 million raise, and Olema's stock price increase and raise on the back of Roche's breast cancer data. *This episode aired on November 21, 2025.
Dave Rubin of "The Rubin Report" talks about CNN's Kaitlan Collins grilling Jasmine Crockett live on-air about how she misled people by lying to try to make it sound like Lee Zeldin had taken money from Jeffrey Epstein when it was someone else who had the same name; Democrat Stacey Plaskett desperately trying to explain to CNN's Pamela Brown and Wolf Blitzer why she was texting with Jeffrey Epstein during a house testimony hearing; Democrat Ayanna Pressley getting annoyed when a BBC News host repeatedly points out that Democrats didn't seem to care about Jeffrey Epstein during the 4 years that Joe Biden was president; hidden camera footage of Larry Summers awkwardly explaining to his class his shame regarding his past associations with Jeffrey Epstein and why will be stepping down from the OpenAi board but continuing to teach courses at Harvard University; Scott Jennings explaining to Newsmax's Rob Schmitt why Democrats sudden desire to get the Epstein files is more likely to hurt Democrats than Donald Trump and the Republicans; Zohran Mamdani telling PIX11 News' Dan Mannarino how he plans to prevent any future ICE raids from happening in NYC; and much more. Dave also does a special "ask me anything" question-and-answer session on a wide-ranging host of topics, answering questions from the Rubin Report Locals community. WATCH the MEMBER-EXCLUSIVE segment of the show here: https://rubinreport.locals.com/ Check out the NEW RUBIN REPORT MERCH here: https://daverubin.store/ ---------- Today's Sponsors: Noble Gold Investments - Whether you're looking to roll over an old 401(k) into a Gold IRA or you want physical gold delivered right to your home Noble Gold makes the process simple. Download the free wealth protection kit and open a new qualified account and get a FREE 10-ounce Silver Flag Bar plus a Silver American Eagle Proof Coin. Go to http://DaveRubinGold.com Juvent - Stop joint pain and stiffness with the Juvent Micro-Impact Platform. In the US, the Juvent device is considered investigational for the treatment of osteoporosis or improvement/maintenance of bone mineral density. Our claims have not been reviewed or cleared by the FDA to treat any disease or condition. The JUVENT® Micro-Impact Platform® is registered as a Class I medical device for exercise and rehabilitation." Go to http://Juvent.com/RUBIN and use the code RUBIN to save $300 on your own Juvent. Brickhouse Nutrition - The most impressive health and nutrition products in the industry are like LEAN, CreaTone and Field of Greens are now 30% off. But hurry, because these Black Friday deals go fast. Go to: http://BrickhouseSale.com to get 30% off!
This week Erin shares her new hobby of reading rare books from the 1930s, and Bryan gets back to smoking on the set of a short film in New York. Bryan covers annual polls from YouGov/The Economist and Gallup showing support for gay marriage and trans rights is at its lowest level in the last 10 years. Erin discusses how the NHS in the UK is now including menopause screening in routine health checks, plus how the FDA is removing black box warnings from most menopausal therapy products. To subscribe to Erin's Substack click here. For tickets to Dead Pilots Society on 12/7 in LA click here.See omnystudio.com/listener for privacy information.
Senator Rand Paul (R-Kentucky) joins Chris Cuomo to break down why the fight over the Epstein files has become a test of public trust — and why he supported full disclosure even while warning people not to expect bombshell revelations. Cuomo presses Paul on how Washington keeps feeding suspicion through secrecy and mixed messages, what real accountability would look like, and why both parties are too comfortable letting the public assume the worst. They also dig into the surprise hemp ban buried in the shutdown bill, Paul's clashes with Mitch McConnell over industry pressure, and how a $25 billion sector got kneecapped without a real debate. From Venezuela to war powers to the politics of fear inside Congress, Paul explains why he believes leaders in both parties are avoiding tough choices as the country drifts deeper into dysfunction. Follow and subscribe to The Chris Cuomo Project on Apple Podcasts, Spotify, and YouTube for new episodes every Tuesday and Thursday: https://linktr.ee/cuomoproject Join Chris Ad-Free On Substack: http://thechriscuomoproject.substack.com Support our sponsors: For a limited time, our listeners are getting an additional $20 Off with code TAKE20. Head to Superpower.com and use code TAKE20 at checkout for $20 off your membership. Take advantage of Soul's Black Friday-Cyber Monday deal now! For a limited time, get 40% off your entire order! Go to http://GetSoul.com and use the code CUOMO. Ready to give Rugiet a try? Get 15% off your first order by going to http://rugiet.com/CUOMO and using code CUOMO. Disclaimer - Rugiet prescriptions are compounded medications, available only if prescribed following an online consultation with a licensed clinician. Compounded drugs can be prescribed by federal law, but are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing. Individual results may vary. Full safety information available at Rugiet.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Dylan Beynon, founder of Mindbloom, shares the deeply personal story behind building the first at-home ketamine therapy platform. After losing his mother and sister to severe mental illness, Dylan became determined to bring psychedelic medicine into mainstream healthcare. He explains the neuroscience of how ketamine creates neuroplasticity—allowing the brain to rewire itself—and why these treatments are showing 10x better outcomes than SSRIs. From navigating FDA breakthrough therapy designations to dismantling decades of stigma from Nixon-era drug policy, Dylan reveals how Mindbloom is democratizing access to treatments that were once only available in $5,000 in-person clinics. Hosted on Acast. See acast.com/privacy for more information.
In this edition of Essential, we've got updates on some big compounding news — like the FDA's long-overdue decision to remove the boxed warning from some menopause hormone-replacement therapy drugs. (And yes, that's important for compounding pharmacists!) We also look at the hubbub at FDA over what (allegedly) was behind the decision that would have effectively banned compounding with desiccated thyroid extract, plus some stories from the states, and more. This month's deep dive: Mythbusting, compounded-GLP-1 style! What have the big drugmakers been saying, and how much of it is true? They're spreading stories, but our experts put them to the test. Don't miss out! Links Join APC today: https://a4pc.org/membership FDA to remove boxed warning from HRT medications: https://archive.ph/R8DJD An example of what appears to be an op-ed pushed by a pharma company. The writer, a “former healthcare professional,”doesn't appear to exist: https://archive.ph/OPNWr Find a legitimate, licensed compounding pharmacy: https://a4pc.org/isitlegit Benefits of becoming an APC PFM: https://a4pc.org/pfm
“My most powerful content is when I lead with my voice as a mom because I have the same concerns about keeping my kids safe as my audience does. It's a powerful and effective way to find common ground with people,” says Dr. Jess Steier, a popular public health scientist and science communicator seeking to bridge divides and foster trust through empathetic, evidence-based communication. Dr. Steier has several platforms from which to do this work, including Unbiased Science -- a communication hub that uses multiple social media platforms and other communications channels to share validated health and science information -- and as executive director of the Science Literacy Lab, a nonprofit organization dedicated to reaching a diverse audience seeking clarity and reliable information on scientific topics. “The science is less than half the battle,” she explains. “It's about how to communicate with empathy.”Join Raise the Line host Lindsey Smith for a valuable conversation that explores:What sources Dr. Steier relies on to validate informationHow she uses “escape room” exercises to train clinicians on empathetic communicationWhy tailored, story-driven messages reach audiences more effectively than facts.Mentioned in this episode:Unbiased Science If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.
In celebration of Women's Hormone Health - Welcome to this special series of Wellness Junkies, where over the next few weeks we're shining a spotlight on women's health — specifically perimenopause, menopause, HRT, and everything in between. We're revisiting some of our favorite women's health episodes following some big news from the FDA.In this episode of Wellness Junkies, we dive deep into the often-taboo topics surrounding women's health with our special guest, Dr. C, also known as The Vag Doc on social media. With over 16 years of experience as a board-certified OB-GYN, Dr. C has made a name for herself on social media by breaking down complex issues related to gynecology (from periods to menopause) with clarity, compassion, and a touch of humor.The conversation kicks off with Dr. C sharing her journey into social media, highlighting the lack of open discussions about gynecology and midlife women's health. She emphasizes the importance of empowering women to ask questions about their bodies, especially during the often confusing transitions of perimenopause and menopause.Dr. C treats us to a wealth of information as she answers common questions about IUDs, hormone replacement therapy (HRT), and the changes women experience during menopause. She explains the benefits of keeping an IUD during midlife, the importance of estrogen for vaginal health, and how to navigate hormone levels effectively.The episode also touches on the significance of pelvic floor therapy, and encourages women to seek help and not to feel embarrassed about their health concerns, reinforcing that there is no shame in asking questions.As the episode wraps up, Amy and Melissa engage in a fun myth or fact segment, tackling common misconceptions about women's health, including the impact of wearing leggings on yeast infections.Join us for this enlightening and entertaining episode as we break down barriers and foster a community where women's health is discussed openly and honestly. Whether you're navigating menopause, considering an IUD, or simply seeking to understand your body better, this episode is packed with valuable information and insights from a trusted expert in the field.Brands/Mentions + Shop this episode: Shop here For More on this Episode: Read the full show notes hereJoin the community:Follow us @wellnessjunkiesofficial on InstagramSubscribe to our newsletterShop this episode + our faves on ShopMyShopNEW! Follow us @wellnessjunkies on YouTube and TikTokFollow Amy @amynicolle on TikTokVisit www.wellnessjunkiesofficial.comShop our Amazon StoreSay hi: press@wellnessjunkiesofficial.comPlease subscribe, rate, review + share to help us grow the community
In case you missed it, last week was quite the week in the menopause world. The FDA made a landmark decision to remove all black box warnings from estrogen products and to update the labels of individual products. I was in the room where it all happened and in this episode, I'm going to break it all down for you. But here's the headline- this label change is overall, a good thing, a very good thing. A transcript of this podcast, along with photos and graphics, can be found on DrStreicher.Substack.com In this episode: A historical perspective of how the Black Box label came to be on all estrogen products A review of the Women's Health Initiative Study (WHI) that lead to the specific warnings on the label. The fall out from the release of the WHI The Problems with the Black Box label on estrogen products Class Labeling The difference between oral, transdermal and local vaginal estrogen. How the required black box label influenced the likelihood of physicians writing a prescription for estrogen, and the likelihood that women would use hormone therapy. Why I never stopped prescribing estrogen Last week's announcement from the FDA If it is medically appropriate to remove the black box warning from local vaginal estrogen If it is medically appropriate to remove the black box warning from systemic estrogen The inaccurate messaging during the FDA press conference The POLITICS of WHY the FDA removed the Black Box warnings Related Podcasts: Episode 124 All Hormones Are Not Created Equal with Dr. James Simon Episode 164 Is Bioidentical Always Best? Episode 181 The FDA Roundtable on Menopausal Hormone Therapy Related Substack Articles Top 20 Questions about Local Vaginal Estrogen Is Bioidentical Always Best? BLOOD CLOTS and ESTROGEN: The Facts Crises at the FDA Why RFK is a Scary Choice for HHS Dr. Streicher is on SUBSTACK DrStreicher.Substack.com Articles Monthly newsletter All COME AGAIN podcast episodes Monthly News Flash Reports on recent research Monthly Zoom Ask Me Anything Webinar Information on Dr. Streicher's COME AGAIN Podcast- Sexuality and Orgasm Lauren Streicher MD, is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, the founding medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause, and a Senior Research Fellow of The Kinsey Institute, Indiana University. She is a certified menopause practitioner of The Menopause Society. S Dr. Streicher is the medical correspondent for Chicago's top-rated news program, the WGN Morning News, and has been seen on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBCNightlyNews,20/20, and World News Tonight. She is an expert source for many magazines and serves on the medical advisory board of The Kinsey Institute, Self Magazine, and Prevention Magazine. She writes a regular column for The Ethel by AARP and Prevention Magazine. LINKS Subscribe To Dr. Streicher's Substack Information About the COME AGAIN Podcast Dr. Streicher's CV and additional bio information To Find a Menopause Clinician and Other Resources Glossary Of Medical Terminology Books by Lauren Streicher, MD Slip Sliding Away: Turning Back the Clock on Your Vagina-A gynecologist's guide to eliminating post-menopause dryness and pain Hot Flash Hell: A Gynecologist's Guide to Turning Down the Heat Sex Rx- Hormones, Health, and Your Best Sex Ever The Essential Guide to Hysterectomy Dr. Streicher's Inside Information podcast is for education and information and is not intended to replace medical advice from your personal healthcare clinician. Dr. Streicher disclaims liability for any medical outcomes that may occur because of applying methods suggested or discussed in this podcast.
20201 Vital Plan & Coffee for Heart Health Podcast | Dare To Be Vital BookFIVE PRIMARY POINTS of the PODCAST1. Vitamin D Dramatically Reduces Heart Attack RiskNew American Heart Association data shows that maintaining vitamin D levels >40 ng/mL for ~4 years cuts recurrent heart attack risk by 52%. Most participants required 5,000 IU/day—far above the current FDA recommendation—to reach optimal levels, making vitamin D testing and personalized supplementation a critical and cost-effective intervention.2. Structured Exercise Improves Cancer SurvivalA large randomized trial in colorectal cancer patients found 90% survival with structured exercise vs. 83% with health education alone (a 42% relative reduction in mortality). Supervised and behaviorally supported exercise—not just information—is required to produce this survival advantage.3. Exercise Should Be Prescribed as Medicine for Cancer PatientsThe transcript highlights mechanisms—myokines, reduced inflammation, better fitness, and increased natural killer cell activity—that explain why exercise reduces cancer mortality. Recommendation: oncologists should prescribe personalized strength and fitness programs as part of cancer care.4. Exercise Is One of the Most Powerful Sleep OptimizersA study of 380 medical students showed:* Low physical activity = poor sleep quality* Being overweight or stressed worsens sleep* Strength training is the most effective exercise modality for improving sleep.The message: Use movement—especially strength training—to break the “doom loop” of poor sleep and inactivity.5. Vitality Is a Skill: Small Daily Choices CompoundThe episode reinforces two overarching themes:* Vitality is a skill you can learn, practice, and improve.* Vitality powers performance—especially through the synergy of exercise, sleep, vitamin D, strength, and connection.The weekly action: Get your vitamin D level checked and optimize it with guidance from your doctor.Copyright VyVerse LLC, All Rights Reserved This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit vitalityexplorers.substack.com/subscribe
We love to hear from our listeners. Send us a message.In episode 116 of Cell & Gene: The Podcast, Host Erin Harris talks to Dr. Arun Upadhyay, Chief Scientific officer, Head of Research and Development at Ocugen to discuss how the company's modifier gene therapy platform is redefining treatment possibilities for inherited retinal diseases such as retinitis pigmentosa, Stargardt disease, and geographic atrophy. Dr. Upadhyay explains how Ocugen's gene-agnostic approach differs from traditional single-gene therapies by targeting shared disease pathways to preserve photoreceptors and slow vision loss across diverse genetic mutations. He also shares key lessons learned from advancing OCU400, the first modifier gene therapy to receive a broad FDA indication for retinitis pigmentosa, including challenges in clinical trial design, endpoint selection, and manufacturing scalability.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn
Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the intricate tapestry of scientific advancements, regulatory decisions, and strategic maneuvers shaping our industry.One of the notable stories involves Agios Pharmaceuticals, which is pushing forward with its sickle cell disease treatment, Pyrukynd, for FDA approval. This comes despite mixed results from their Phase 3 clinical trials, which led to a significant drop in their stock value. This scenario underscores the complexities of navigating clinical trial outcomes while pursuing breakthroughs in treating challenging diseases like sickle cell.Arrowhead Pharmaceuticals has marked a significant milestone with the FDA's approval of Plozasiran. This achievement not only marks Arrowhead's entry into the commercial sector but also highlights the competitive dynamics within biotech, as companies like Ionis Pharmaceuticals vie for market dominance with innovative therapies. Further strengthening its position, Arrowhead also received FDA approval for Redemplo, a siRNA-based therapeutic for rare genetic metabolic disorders. Despite facing volatility due to safety concerns in its partnership with Sarepta Therapeutics, this approval underscores RNA interference therapies' potential in precision medicine.In corporate strategy news, Alkermes is making moves to acquire Avadel Pharmaceuticals, offering up to $2.37 billion and overshadowing a competing bid from Lundbeck. Such acquisitions are part of a broader trend of consolidation in the industry aimed at expanding portfolios and market reach. Avadel's decision to accept Alkermes' revised offer over Lundbeck's bid highlights ongoing consolidation trends as companies expand their portfolios in competitive markets like narcolepsy drugs.On the investment front, Celltrion has committed $478 million to upgrade a U.S. manufacturing facility acquired from Eli Lilly. This expansion is crucial for increasing manufacturing capabilities within the biosimilars sector, where demand for cost-effective therapeutics is on the rise. Additionally, Celltrion's exploration beyond biosimilars with a potential $350 million deal involving Trioar's antibody platform demonstrates ambition to diversify its portfolio towards innovative biologics.Teva Pharmaceuticals is fostering innovation by inviting startups to tackle key challenges within biopharma through a global platform. This initiative reflects a growing trend toward open innovation and collaboration, seeking novel solutions to complex issues across research and development and manufacturing efficiencies.In regulatory news, the controversial $7.4 billion settlement plan involving the Sackler family and Purdue Pharma has received approval from a bankruptcy judge. This paves the way for Purdue's transformation into Knoa Pharma and highlights ongoing legal and ethical reckonings related to opioid liabilities within the industry.Cytokinetics remains committed to its independent path as it awaits FDA approval for its cardiovascular drug Aficamtem. The company's determination to commercialize without big pharma support reflects a trend where smaller biotech firms strive for autonomy while bringing first-in-class drugs to market.On an infectious disease front, Merck has demonstrated significant progress with its HIV treatment Islatravir in Phase 3 trials. This places Islatravir as a potential competitor against Gilead's Biktarvy, showcasing ongoing innovation within antiviral drug development.Additionally, Dexcom has gained clearance for its type 2 diabetes software integrating continuous glucose monitoring technology. This advancement exemplifies how digital health technologies are transforming chronic disease management bySupport the show
En el Radar Empresarial, Capital Intereconomía analiza los resultados de Nvidia, que vuelve a batir previsiones y aleja los temores de burbuja en la inteligencia artificial. La compañía consolida su liderazgo en el sector y devuelve la confianza a los mercados tecnológicos. En la entrevista del día, Carlos Buesa, CEO de Oryzon Genomics, detalla el avance de la biotecnológica en el campo de la epigenética aplicada a la salud mental. La compañía destaca por sus terapias de precisión y por el desarrollo de vafidemstat, su molécula estrella, cuya fase III está pendiente de validación por parte de la FDA. Oryzon prepara una ampliación de capital de hasta 125 millones para financiar ensayos clínicos y reforzar su pipeline, mientras reduce pérdidas y multiplica ingresos en los nueve primeros meses del año. En el Foro de la Inversión, Javier García Fernández, director de Velaria Inversores, analiza el momento del mercado tras las correcciones recientes ligadas a las dudas sobre la IA y la resaca de las cuentas de Nvidia. Explica cómo Velaria ofrece asesoramiento personalizado, revisa carteras y propone fondos adecuados según perfil de riesgo, destacando su acompañamiento continuo al cliente en fases de volatilidad. La jornada concluye con el consultorio de fondos junto a Gabriel López, CEO de Inverdif, resolviendo dudas sobre estrategias y oportunidades en la recta final del año.
In this episode, Anders Varner, Doug Larson, and Travis Mash sit down with Matt Brown, Director of Business Development at Springbok Analytics, to explore the cutting edge world of MRI based muscle analysis. Matt breaks down the origins of Springbok, how the company grew from a university research lab solving cerebral palsy surgical problems into one of the most advanced muscle segmentation platforms on the planet, and why professional sports teams, medical researchers, and longevity practitioners are all adopting this technology. From 15 minute full body protocols to AI driven segmentation of 144 muscles, Springbok is redefining what is possible in muscle profiling and objective performance measurement. The conversation dives into real world application, how Springbok helps pro athletes understand tissue quality, fat infiltration, tendon health, asymmetries, compensations, and injury risk with unprecedented precision. Matt shares examples across the NBA, NFL, soccer, and clinical research showing how MRI data is being used to shorten rehab timelines, guide targeted strength work, map scar tissue, and track atrophy after major injuries like ACL tears. The group contrasts traditional tools like DEXA with what is now possible using MRI, individualized baselines, normative values by sport and position, and 3D interactive models that reveal exactly where muscle is strong, weak, or compromised. Finally, the team covers the massive opportunity in longevity and consumer health. They discuss how muscle quality predicts aging trajectories, why fat infiltration accelerates decline, and how Springbok's new FDA cleared body composition capabilities unlock deeper insights into visceral fat, liver fat, bone density, and long term risk. Doug outlines how Rapid Health Optimization is partnering with Springbok through Optima Muscle to bring these pro level analytics to everyday people, combining MRI data with elite coaching, physical therapy, and strength programming to create personalized, actionable plans that maximize performance and minimize injury. This episode is a powerful preview of where the future of muscle health, performance diagnostics, and longevity is headed. Learn more at: OptimaMuscle.com Links: Barbell Shrugged on Instagram Springbok Analytics on Instagram Anders Varner on Instagram Doug Larson on Instagram Coach Travis Mash on Instagram
About this episode: Robotic telesurgery allows providers to conduct minimally invasive surgeries across long distances, reaching remote communities. In this episode: Binita Ashar, a surgeon with a background in policy, discusses the revolutionary role this technology can play in medicine and what issues need to be addressed—from cost to cybersecurity—in order to greenlight more procedures in the United States. Guests: Binita Ashar, MD, MBA, is a general surgeon who previously served as the Director of the FDA's Office of Surgical and Infection Control Devices. She also serves on the board of the Society of Robotic Surgery. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Exclusive look at groundbreaking remote robotic surgery: Patient was in Africa; doctor was in Florida—ABC News WHO and Society of Robotic Surgery launch health innovation initiative to expand access to virtual care and telesurgery—WHO Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
In this episode, Jess and Sarah welcome Dr. Joe Schwarcz, a renowned chemist and science communicator, to explore a range of current scientific topics. The scientists discuss a recent infant formula recall and the FDA's removal of black box warnings from estrogen products, providing context for these regulatory decisions. Dr. Schwarcz addresses the complexities of nutrition research, debunking common misconceptions about superfoods and food additives while emphasizing the importance of understanding food safety. Throughout the conversation, the experts examine the challenges of effective science communication in an era of widespread misinformation. The episode underscores the critical need for improved public science education and clearer communication strategies to help people navigate complex health and safety information in their daily lives. Video available on YouTube: https://youtu.be/0kvnw6eE_2I (00:00) Intro and Public Health Update (03:41) What Is A News Item That Caught Your Attention And Why? (Removing Black Box Warning From Estrogen Products) (07:45) The Problem With The Blanket Approach To Ultraprocessed Foods (11:47) Better Not Burn Your Toast - Dr Joe's New Book (15:29) The Importance (And Challenge) Of Science Communication (22:39) Risk Approach Vs. Hazard Approach (26:51) Are SuperFoods Real? (30:45) What Is Giving Hope In Science And Public Health? https://ecwpress.com/products/better-not-burn-your-toast Better Not Burn Your Toast: The Science of Food and Health on Amazon ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices
This week, trauma expert Dr. Aimie Apigian is here to change how we understand trauma. She shares how becoming a foster parent led her into trauma healing—and y'all, her story is powerful. Dr. Aimie explains the difference between stress and trauma, reveals how our bodies hold onto past experiences, and offers practical steps for us to start releasing them. Get ready for real talk, actionable tools, and hope—this episode is for all of us ready to heal from the inside out.In this episode:How becoming a foster parent shaped Dr. Amie's path to becoming a trauma expertThe three qualities shaped by trauma responsesHow the body recognizes and stores traumaCommon patterns of stored trauma in the bodyActionable steps to begin healing trauma in the bodyHere is my favorite quote from this episode:"The body does not allow us to leave our past in the past." - Dr. Aimie ApigianExperience Bible Life Guides: Forgiven and Free — a 21-day Bible-based journey to emotional freedom, available free at https://try.biblelifeguides.com/products/forgiven-free-with-kim-gravelTake the Quiz: Which Maribelle and the Manger character are you? Find out here: https://bit.ly/4pxUqF8If you want your questions answered then leave a comment or call me and leave me a voicemail at 404-913-6460There is BONUS CONTENT in our free newsletter so make sure to subscribe at https://www.kimgravelshow.comNEW! Order Kim's Holiday Children's BookEmbark on a magical adventure with five friends as they journey together to witness the birth of Jesus! It's a heartwarming holiday tale your whole family will love.Kim's brand-new storybook Maribelle and the Manger is available now: https://maribelleandthemanger.com/?utm_source=lwya.beehiiv.com&utm_medium=newsletter&utm_campaign=pre-order-kim-s-new-book&_bhlid=075a4287c5257cbe2d43cc23e857262cc9cf39cdConnect with Dr. Aimie Apigian:InstagramLinkedInYouTubeWebsitePodcast: The Biology of TraumaBook: The Biology of TraumaConnect with Me:YouTubeFacebookInstagramTikTok WebsiteNew episodes of The Kim Gravel Show drop every Wednesday at 6pm EST.Support our show by supporting our Sponsors:Aura FramesThe holidays are almost here, and Aura Frames is the gift that brings memories to life. Aura is a digital photo frame with unlimited storage that can be updated instantly from any phone, anywhere. It's an easy way to share moments, keep traditions alive, and feel connected every day. You can't wrap togetherness, but you can frame it.For a limited time, visit https://on.auraframes.com/KIM and get $45 off Aura's best-selling Carver Mat frame with promo code KIM at checkout. This exclusive Black Friday/Cyber Monday offer is their best of the year—order before it ends!HERSMenopause can bring hot flashes, fatigue, brain fog, and other challenging symptoms—but getting help doesn't have to be hard. HERS now offers menopause care through their trusted online health platform. Complete a simple medical intake, and if eligible, a licensed provider creates a personalized treatment plan with access to FDA-approved options. Many women start feeling relief in 4–6 weeks, with better sleep, fewer hot flashes, and improved overall well-being.Visit https://www.forhers.com/kim to get a personalized plan. Not available in all 50 states. Perimenopause & Menopause by Hers includes hormonal health support, educational resources, digital tools, and prescription options, if appropriate. See website for full details, important safety information, and restrictions.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
On this episode of Vitality Radio, Jared opens part one of a powerful new series on what he calls the hidden epidemic—the widespread and silent impact of endocrine-disrupting chemicals (EDCs) on hormones, brain chemistry, metabolism, and long-term health. After more than a year and a half of deep research, Jared and his wife Jen have uncovered how these chemicals mimic hormones, block receptors, interfere with detox pathways, disrupt neurotransmitters, and contribute to challenges like fatigue, low motivation, stubborn weight gain, PMS, anxiety, sleep struggles, and declining testosterone in both men and women.This episode explains why the endocrine system is struggling more than ever, how EDCs create thyroid chaos, hormonal imbalance, and neurochemical disruption, and what steps you can begin taking right now to start clearing these compounds from your environment and your body. If you've been dealing with symptoms that “don't match” your lab work, if you've struggled to feel balanced despite doing the right things, or if you've suspected environmental chemicals may be affecting you or your family, make sure to listen to Part 2 and stay tuned for future episodes. This is a big issue, but there are real answers and we are bringing them to you very soon on Vitality Radio.Products:LiverVitalityEndoCleanseBack On TractVital D3/K2Source Naturals Nattokinase 50mg - Vitality Radio POW! Product of the Week $11.99 per bottle (almost 70% off) with PROMO CODE: POW18Additional Information:Vitamin K2 and the Calcium Paradox: How a Little-Known Vitamin Could Save Your Life by Dr. Kate RhéaumeVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
Stem cells and exosomes continue to shape conversations in the medical aesthetics and wellness industry, but understanding what is legally allowed is just as important as understanding the science. In this episode, Dr. Jordan Plews, PhD, a scientist and entrepreneur in biotechnology and stem cell research, breaks down how these products work and the regulatory challenges surrounding them. Tune in to understand how medical practices can legally use these products and the risks of going off-label or using unapproved treatments.Chapters00:00 Intro00:47 Banter 07:16 Tell us about you and your background.09:21 Jordan, can you please explain what stem cells and exosomes are?12:38 Is there a product out there that is similar to stem cells?15:12 Asking for a Friend. Our first question we are asking for a friend, is for someone who is an owner of an aesthetic practice, and they are interested in treating patients with stem cells or exosomes. From your perspective, can a medical practice offer stem cells or exosomes?20:16 Talk about the risk patients and providers are taking on when they go down that road.22:53 What would you advise clients that are thinking about adding these products into their practice?26:33 Access+27:09 Legal Takeaways30:09 OutroWatch full episodes of our podcast on our YouTube channel: https://www.youtube.com/@byrdadattoStay connected for the latest business and health care legal updates:WebsiteFacebookInstagramLinkedIn
The FDA just made history, and it changes everything for women's health. After 23 years, the FDA removed the black box warning from estrogen therapy. This is a MASSIVE win for women everywhere. What we were told about estrogen being risky for breast cancer, stroke, and heart attack? Completely inaccurate. We'll soon break down what this means for you, and why testosterone therapy for women is next. In the meantime, here are the TOP 5 MOMENTS FROM MENOPAUSE MASTERY: 1️⃣ 5 Dietary Changes to Get Rid of Meno Belly The foundation matters more than the biohacks. Here are 5 dietary changes that reduce visceral fat, improve insulin sensitivity, and lower disease risk.
As we head into the busy holiday season, we're talking about something we all want-healthy, glowing skin that reflects how good we feel inside. Meet my latest guest Autumn Groscost, a certified physician assistant who practices with St. Clair Medical Group Plastic Surgery. Autumn shares how you can feel your best from the inside out and the importance of self-care even when life gets hectic. In this episode, we discuss some of the most well-known aesthetic treatments and how they can help your complexion stay bright through the busy holiday season. From neuromodulators like Botox and Juveau, to dermal fillers and the FDA‑approved SkinPen microneedling, we cover practical timelines for treatments and their natural, confidence‑boosting results. If your interested in learning more or want to schedule a personalized consultation with Autumn visit https://physicians.stclair.org/scmg-plastic-surgery/ Thank you St. Clair Health for partnering with me to bring valuable information from medical experts outside the exam room. All episode are available on all the major audio platforms. As well as Jenny D.'s YouTube channel. Make sure to Subscribe and Follow. http://www.youtube.com/@Spillwithmejennyd If you want like to be guest or a sponsor on Spill with Me Jenny D. Show contact Kelli Komondor at kelli@k2creativellc.com To view previous episodes and fill out a disclaimer to be a guest under Tell us Your Story visit https://www.spillwithmejennyd.com/
This is a free preview of a paid episode. To hear more, visit meetthemess.substack.comMove over, Meet the Press—it's time to MEET THE MESS!This week on the podcast, Jen and Karyn are back! The House voted to release the Epstein files, but will it actually happen? Meanwhile, Trump delivers a completely bananas speech to McDonald's franchise owners and tells a female reporter, “Quiet, piggy.”Also on deck: a behavioral scientist breaks down what it means when someone does (or doesn't) return their cart. Plus, Kim Kardashian fails the bar exam, the FDA removes the black box warning from menopause hormone therapy, and a flamingo escapes a British zoo and decides to retire on a beach in the south of France. And finally, do you have a preferred font?On Meet the Mess, bestselling authors Jen Lancaster & Karyn Bosnak dive into the messiest news stories and hottest topics of the week to give a fresh and entertaining take on current events and life in general. An extended video version with the “Hot Mess of the Week” is available to paid Substack subscribers. Visit meetthemess.substack.com for more.Meet the Merch:• https://www.etsy.com/shop/MeetTheMessConnect with us on Instagram:• https://www.instagram.com/meetthemesspod• https://www.instagram.com/jennsylvania• https://www.instagram.com/karynbosnakConnect with us on TikTok:• https://www.tiktok.com/@meetthemess• https://www.tiktok.com/@karynbosnak
This week on Swimming with Allocators, Jay Rongjie Wang, Founder and CEO of Primitiva Global, shares her journey from her pioneering upbringing shaped by her mother's tech entrepreneurship to becoming a leading venture investor bridging Silicon Valley, Hong Kong, and Shanghai. Jay discusses the importance of authenticity and “congruence” in investment decisions, her “impossible triangle” theory for evaluating AI opportunities, and cross-border fundraising strategies. Listeners will gain actionable insight into aligning personal strengths with business practices, understanding global LP/GP dynamics, and balancing boundless curiosity with focused execution in the rapidly evolving world of tech and venture capital. Also, don't miss our insider segment as Idan Netser and Jason Kropp from Sidley discuss key tax incentives for venture funds, including carried interest treatment and Qualified Small Business Stock benefits, as well as recent FDA regulatory changes impacting biotech and medtech startups, offering timely guidance for VC investors and founders.Highlights from this week's conversation include: Welcoming Jay to the Episode (0:22) Impact of Parenting on Risk, Creativity, and Early Career Choices (5:24) Lessons Learned from Running Community Website: Career Preparation (7:17) Discussion of Gender Dynamics, Over-Preparation, and Confidence (10:00) Traits for Successful Fund Managers: Concept of Congruence (11:38) Practical Framework for Identifying "Winner Energy" and Reference Checks (17:55) Consistency in Feedback About GPs (21:46) Regulatory Topics: Carried Interest, Tax, and FDA Insights (23:54) Energy Management, Executive Capacity, and Inner Focus (28:48) Impossible Triangle Theory on AI Progress and Investment Filtering (30:27) Applying the Theory: GPU and Data Center Investments (36:06) Fundraising Successes Outside the US and Motivations of International LPs (39:09) Balancing Curiosity with Focus for Investors (41:20) Personal Advice on Career Methodology and Venn Diagram Specialization (44:24) Final Thoughts and Takeaways (45:15) Primitiva Global is a family office and investment platform operating across Silicon Valley and Hong Kong. Primitiva backs first-check venture managers and invests in companies expanding the frontiers of artificial intelligence, deep technology, and global innovation. The firm combines deep research, top-down analysis, and hands-on partnership to support the next generation of builders and allocators. Learn more at www.primitivaglobal.com Sidley Austin LLP is a premier global law firm with a dedicated Venture Funds practice, advising top venture capital firms, institutional investors, and private equity sponsors on fund formation, investment structuring, and regulatory compliance. With deep expertise across private markets, Sidley provides strategic legal counsel to help funds scale effectively. Learn more at sidley.com. Swimming with Allocators is a podcast that dives into the intriguing world of Venture Capital from an LP (Limited Partner) perspective. Hosts Alexa Binns and Earnest Sweat are seasoned professionals who have donned various hats in the VC ecosystem. Each episode, we explore where the future opportunities lie in the VC landscape with insights from top LPs on their investment strategies and industry experts shedding light on emerging trends and technologies. The information provided on this podcast does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this podcast are for general informational purposes only.
When David Fajgenbaum nearly died of Castleman disease for the fifth time, he decided to take fate into his own hands. Using his medical training, he searched for an existing drug that might save his life—and found one. Now his organization, Every Cure, is scaling the same approach to uncover hidden treatments for other diseases with no known cure. David and Claudia discussed: How Every Cure is using AI to test 75 million possible disease-drug combinations The perverse incentives that keep generic drug repurposing in the shadowsWhy the hardest part of innovation isn't discovery, it's getting proven treatments into clinical practiceRepurposing existing drugs makes so much sense. But as David points out, there's no market for it:“Once a drug is generic.. the price is going to plummet… And even if you were to double the sales of your drug because you found a new disease area, now you've gone from 1% to 2% of what you got before… So there's no incentive whatsoever for our system to find a new use for a generic drug. Zero incentive.”Relevant LinksLearn more about Every CureRead David's book Chasing My Cure: A Doctor's Race to Turn Hope Into ActionWatch David's TEDTalk Listen to David's Podcast interview with Adam GrantGet info on the Dada2 FoundationWatch a video on Matt Might's story About Our GuestDavid Fajgenbaum, MD, MBA, MSc, is co-Founder & President of Every Cure and a physician-scientist at the University of Pennsylvania, where he is one of the youngest faculty members ever to receive tenure at Penn Medicine. He is also the national bestselling author of Chasing My Cure: A Doctor's Race to Turn Hope Into Action, which is being adapted into a film by Forrest Gump producer Wendy Finerman. During medical school, Fajgenbaum discovered a treatment that saved his own life and founded the Castleman Disease Collaborative Network. He has advanced 13 more repurposed treatments for cancers and rare diseases and co-founded Every Cure to unlock more hidden cures from existing medicines which has received over $100M from ARPA-H and TED's Audacious Project. He also serves on the Board of Directors for the Reagan-Udall Foundation for the FDA. One of the youngest recipients of multiple top NIH and FDA grants, Fajgenbaum has authored over 100 scientific papers in leading journals, including The New England Journal of...
In this video, I'm diving into a question I'm asked all the time — should women use male testosterone products? The answer might surprise you. Testosterone therapy can be a safe and effective treatment for Hypoactive Sexual Desire Disorder (HSDD) and other symptoms of low testosterone in women — but the key lies in dose, delivery method, and medical supervision. I'll walk you through: • The science behind testosterone in women and why it matters for sexual health, energy, and well-being • The difference between FDA-approved male testosterone products and compounded testosterone gels or creams commonly prescribed for women • How dosage adjustments are made for female physiology • A real-life demonstration on how to correctly use topical testosterone products • Important considerations for safety, absorption, and hormone balance It's not about “male vs. female” testosterone — it's about finding the right form and dose to restore optimal function and vitality. Medical Insight: Testosterone is a crucial hormone in women too — affecting libido, bone density, muscle mass, and overall mood. Low levels can contribute to fatigue, loss of desire, and decreased quality of life. As always, hormone therapy should be personalized and physician-guided.
Interim CEO of ASCP and host Dr. Ali Brown sits down with Dr. Eric Konnick and Michelle Campbell, MLS(ASCP) to discuss lessons learned from the latest efforts to place laboratory developed tests under FDA oversight. For listeners unfamiliar with LDTs, they begin by establishing what LDTs are and what their value to the lab and patient safety are before debunking common misunderstandings cited by patient advocacy groups regarding their accuracy, validity, and the transparency with which they're developed. They go on to define what FDA oversight would mean for laboratories in terms of cost, time, and labor, contextualizing these added costs in ongoing workforce shortages in the lab. They close their conversation by spotlighting which efforts ASCP and similar organizations made to advocate for the lab were most successful, and describe alternative strategies for updating laboratory regulations, such as modernizing CLIA.
In this episode, Dr. Allyson Brooks, the Ginny Ueberroth Executive Medical Director Endowed Chair of the Hoag Women's Health Institute, discusses how Hoag is transforming menopause care through multidisciplinary collaboration, education, and community engagement. She shares how the FDA's recent hormone therapy update and women's growing advocacy are reshaping the future of midlife health.
In this episode, Dr. Allyson Brooks, the Ginny Ueberroth Executive Medical Director Endowed Chair of the Hoag Women's Health Institute, discusses how Hoag is transforming menopause care through multidisciplinary collaboration, education, and community engagement. She shares how the FDA's recent hormone therapy update and women's growing advocacy are reshaping the future of midlife health.
Jackie takes a well earned deep breath following the completion of the Dim the Lights tour, rails against the glorification of tinned fish, and advises against combining bodily fluid colors in an outfit.Thanks for supporting my sponsors:Home Chef: For a limited time, get 50% off and free shipping for your first box. Plus free dessert for life at www.HomeChef.com/BIBLENutrafol: For a limited time, get $10 off your first month's subscription and free shipping at www.nutrafol.com/biblePique: Get up to 20% off for life, plus a complimentary gift at www.PiqueLife.com/BIBLEAddyi: Check out the FDA-approved treatment for certain premenopausal women who are bothered by low libido and want their sex drive back at www.Addyi.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The FDA is planning to remove the “black box” warning from many hormone treatments for menopause -- a major shift that could change care for millions of women in this country. On this week's Paging Dr. Gupta, we break down what who this treatment could help and what you still need to know about its risks. This episode was produced by Jennifer Lai with assistance from Kyra Dahring and Leying Tang. Showrunner: Amanda Sealy Senior Producer: Dan Bloom Technical Director: Dan Dzula Executive Producer: Steve Lickteig Learn more about your ad choices. Visit podcastchoices.com/adchoices
In this episode of The President's Daily Brief: Newly uncovered emails reveal Jeffrey Epstein's sprawling network of foreign contacts — and his extraordinary claims that he was feeding Russian associates insight into Donald Trump's policy decisions. Poland deploys security forces after a critical rail line to Ukraine is blown up in what officials are calling a suspected act of sabotage. Plus — thousands of demonstrators in Mexico City clash with police during protests over cartel violence and government inaction. And in today's Back of the Brief — a notorious Ecuadorian drug kingpin who faked his own death has finally been captured in Spain, ending four years on the run. To listen to the show ad-free, become a premium member of The President's Daily Brief by visiting https://PDBPremium.com. Please remember to subscribe if you enjoyed this episode of The President's Daily Brief. YouTube: youtube.com/@presidentsdailybrief Rugiet: Ready to give Rugiet a try? Get 15% off your first order by going to http://rugiet.com/PDB and using code PDB. Rugiet prescriptions are compounded medications, available only if prescribed following an online consultation with a licensed clinician. Compounded drugs can be prescribed by federal law, but are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing. Individual results may vary. Full safety information available at https://Rugiet.com Lean: Visit https://BrickhouseSale.comfor 30% off StopBox: Not only do you get 10% Off your entire order when you use code PDB10 at https://stopboxusa.com/PDB10, but they are also giving you Buy One Get One Free for their StopBox Pro. #stopboxpod Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of The PDB Afternoon Bulletin: Russia's oil sector is taking heavy hits on two fronts. Ukrainian drones are striking deep inside the country, while new U.S. sanctions are cutting off key buyers in India and China. We'll explain why this dual pressure is becoming a serious problem for Moscow's war economy. Germany is preparing to lift its freeze on arms exports to Israel, saying the Gaza ceasefire has stabilized enough to reverse restrictions imposed during the height of the conflict. Please remember to subscribe if you enjoyed this episode of The President's Daily Brief. YouTube: youtube.com/@presidentsdailybrief Rugiet: Ready to give Rugiet a try? Get 15% off your first order by going to http://rugiet.com/PDB and using code PDB. Rugiet prescriptions are compounded medications, available only if prescribed following an online consultation with a licensed clinician. Compounded drugs can be prescribed by federal law, but are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing. Individual results may vary. Full safety information available at https://Rugiet.com Lean: Visit https://BrickhouseSale.comfor 30% off StopBox: Not only do you get 10% Off your entire order when you use code PDB10 at https://stopboxusa.com/PDB10, but they are also giving you Buy One Get One Free for their StopBox Pro. #stopboxpod Learn more about your ad choices. Visit megaphone.fm/adchoices
Breaking down the food-pharma cartel—showing how tobacco giants, chemical processors, and billionaire foundations engineered addictive factory food, chronic illness, and a century of medical censorship. Richardson exposes how the Flexner takeover, Rockefeller petro-medicine, and FDA suppression of natural treatments like Laetrile created a monopolized sickness industry that profits from diabetes, cancer, and obesity while silencing dissent.Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.
What if everything you've been told about menopause is wrong? In this episode, I sit down with Dr. Mary Claire Haver — board-certified OB/GYN and leading menopause expert — to unpack the science reshaping women's health. We break down the FDA's recent removal of the 22-year black box warning on hormone therapy, why only 4% of women use HRT today, and how fear and misinformation have shaped decades of care. Dr. Haver also dives into the rise of menopause “biohacks,” from NAD and PRP to the fundamentals that truly move the needle: sleep, strength training, and metabolic health. Her message is simple: Menopause isn't a disease — it's a transition, and you deserve informed, evidence-based support. If you've ever felt dismissed or confused during midlife changes, this conversation will give you clarity, confidence, and the science to advocate for yourself. Follow Dr. Haver:Instagram: @drmaryclaireTikTok: @drmaryclaireWebsite: The Pause LifePre-order The New Perimenopause, set to release on April 7, 2026: https://thepauselife.com/pages/the-new-perimenopause-bookListen to Dr. Haver's podcast, unPAUSED, here: https://thepauselife.com/pages/the-unpaused-podcast *** Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode. Check them out and enjoy exclusive discounts: TroscriptionsGive it a try at https://www.troscriptions.com/NEURO or enter NEURO at checkout for 10% off your first order. TimelineHead to https://www.timeline.com/neuro to get started. Branch BasicsHead to https://www.branchbasics.com and use code NEURO for 15% off. Hollow SocksFor a limited time Hollow Socks is having a Buy 3, Get 3 Free Sale. Head to https://www.ollowsocks.com today to check it out. Jones Road BeautyUse code NEURO at https://www.jonesroadbeauty.com to get a free Cool Gloss with your first purchase. *** I'm Louisa Nicola — clinical neurophysiologist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_***Topics discussed: 00:00 – Intro 01:55 – The FDA removed the “black box” warning for HRT 05:16 – The Social Media Effect on Menopause Education 07:54 – How Doctors Historically Dismiss Women's Symptoms 11:12 – Why So Many Women Get Antidepressants Instead of HRT 14:07 – Life Stress vs Hormone-Driven Symptoms 16:48 – The Timing Hypothesis / Critical Window Explained 19:06 – Why Modern RCTs Aren't Happening 20:10 – Proven Benefits: Bone Health & Osteoporosis Prevention 21:35 – HRT, Dementia, and Brain Health: What the Data Actually Shows 23:16 – Environmental Toxins, Brain Health & Midlife Risk Factors 25:24 – How the Internet Distorts Menopause Education 27:10 – The “Brain Eating Itself” Debate: The Real Science 30:09 – What Brain Fog Really Is During Perimenopause 32:24 – Why High-Functioning Women Struggle the Most 34:03 – Breast Cancer Risk: What the WHI Actually Found 35:00 – Why Sleep Is the First Line of Treatment Learn more about your ad choices. Visit megaphone.fm/adchoices
If you've ever hit a breaking point, the kind that forces you to stop pretending you're fine, this episode is medicine. Emily Fletcher sits down with actress and creative force Tati Gabrielle (You, Chilling Adventures of Sabrina, Kaleidoscope) to explore how pain becomes power when you're willing to meet it head-on. From depression in Atlanta to an identity unraveling to discovering a spiritual practice that rebuilt her from the inside out, Tati shares the raw moments that became her initiation into authenticity. This conversation isn't about bypassing pain, it's about alchemizing it. Turning the collapse into clarity. Turning the wound into wisdom. Turning the struggle into strength. In this episode, we explore: • How to recognize when pain is trying to redirect you • The morning ritual that helped Tati rebuild her life • The difference between numbing pain and transforming it • Why meditation can be a portal for emotional alchemy • The “mind palace” technique she used to rewire her future • How intuition becomes louder when you stop abandoning yourself • What inner child healing actually looks like in daily life • A more empowered way to relate to fate, free will, and resilience Timestamps: • [02:01] When everything broke open — Tati's turning point and the moment pain became her invitation inward. • [06:26] The 7 a.m. ritual that saved her — The simple, self-created practice that pulled her out of depression. • [10:06] Anxiety vs. soul alignment — How she learned to read her body and separate fear from intuition. • [12:18] The “red carpet” vision — The emotional anchor that fueled her transformation and early manifestation wins. • [17:38] The power pivot — How her internal shift created rapid external change (manager, agent, bookings). • [24:38] The body map of intuition — The clearest explanation of where intuition lives vs. where anxiety lives. • [32:49] Life as a video game — A reframe for navigating pain, destiny, and empowerment with play instead of pressure. • [40:57] Mini-resets that regulate the nervous system — The exact micro-practices Tati uses when she spirals. • [48:30] Inside the darkest moments — How she navigates panic, bipolar swings, and the instinct that brings her back. • [53:06] Acting as devotion — How she channels characters as real souls — and why creativity can be healing. Guest Links: • Follow Tati → @tatigabrielle • Watch Tati's work → Netflix: You, Chilling Adventures of Sabrina, Kaleidoscope • IMDb → imdb.com/name/nm5354727 More from Emily & Ziva: • Join Ziva Magic: makemagic.zivameditation.com • Learn Ziva Meditation: preview.zivameditation.com • Free Masterclass: learn.zivameditation.com • Get 15% off with promo code WHYTHIS: whythis.zivameditation.com • Follow on Instagram: @zivameditation • Visit upgradedformulas.com/emily and use code EMILY for 20% off everything at UpgradedFormulas.com. These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider if pregnant/nursing, on medication, or have a medical condition.
Breaking down the food-pharma cartel—showing how tobacco giants, chemical processors, and billionaire foundations engineered addictive factory food, chronic illness, and a century of medical censorship. Richardson exposes how the Flexner takeover, Rockefeller petro-medicine, and FDA suppression of natural treatments like Laetrile created a monopolized sickness industry that profits from diabetes, cancer, and obesity while silencing dissent.Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.
When conventional revascularization fails, can deep venous arterialization offer a new lifeline to limb salvage? Dr. Lucas Ferrer Cardona, vascular surgeon at Ascension and Dr. Miguel Montero Baker, vascular surgeon and medical director at HOPE Clinical Innovation Center join host Dr. Sabeen Dhand for an insightful discussion on deep venous arterialization (DVA). --- This podcast is supported by: RADPAD® Radiation Protectionhttps://www.radpad.com/ --- SYNPOSIS The doctors discuss the progression of deep venous arterialization, highlighting the benefits of open, endovascular, and hybrid approaches. They draw on their personal experiences to share key technical nuances and explore new devices such as the Aveera Boomerang device. They emphasize the critical role of patient selection, family support, and close postoperative surveillance, including weekly wound assessments and monthly ultrasound evaluations. Although currently FDA-approved for no-option chronic limb-threatening ischemia (CLTI), Dr. Baker notes that deep venous arterialization may hold promise even for patients earlier in the disease course.The episode concludes by exploring future directions for deep venous arterialization, highlighting the ongoing need for research to advance limb preservation. --- TIMESTAMPS 00:00 - Introduction03:15 - The Inspiration Behind Their Podcast10:05 - Challenges and Success Stories in Vascular Surgery10:29 - Exploring Deep Venous Arterialization (DVA)25:16 - Hybrid Approaches and Patient Outcomes32:06 - Evolution of Endovascular Techniques37:33 - Patient Selection and Criteria38:52 - Understanding the Biology of Procedures43:57 - Exploring New Techniques and Devices58:52 - Challenges and Considerations01:01:51 - Final Thoughts --- RESOURCES Hybrid superficial venous arterialization and endovascular deep venous arterializationhttps://pubmed.ncbi.nlm.nih.gov/37404577/ Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemiahttps://www.nejm.org/doi/full/10.1056/NEJMoa2212754
Dr. Hoffman continues his conversation with Nathan Jones, CEO of Xlear, Inc.
© 2020-2025 Ivy Podcast Discovery LLC
